Skip to main content

Search Results

57 Results for:

Search
Refine Results
Displaying: 51-57 of 57 Results
Sort by
Canadian Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus
Recommendations were developed using the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) approach...
Sep 23, 2018
Canadian Position Statement on Opioid Therapy
Pain is a prevalent and often severe symptom that impacts global health status for almost every patient with a rheumatic disease. In response to the Guideline for opioid therapy and chronic non-cancer pain published in the Canadian Medical Association Journal...
Nov 23, 2017
MTX info ‘fax-back’ for Pharmacists
Methotrexate remains an important therapeutic agent in Rheumatology, for Rheumatoid arthritis and other systemic and auto-immune diseases. Its prescription and subsequent use is often challenged by mis-information at the dispensing levels, often finding the origin of the mis-information in various […]
Nov 24, 2015
Chronic pain, Diclofenac and Cardiovascular Risk:  Management Algorithm
Algorithm for the Management of High Dose (150 mg daily) Diclofenac Usage in Chronic Pain Patients.
Nov 01, 2014
Cardiovascular Risk with Diclofenac:  Response to Health Canada
This metanalysis deals with the risks of cardiovascular and gastrointestinal events and deaths with the use of high-dose COX-2 inhibitors, diclofenac, and naproxen compared to placebo.. Reviewed by Therapeutics Committee in November 2021 and no changes made.
Nov 01, 2014
Canadian Recommendations for the Management of Spondyloarthropathy
The Canadian Rheumatology Association (CRA) and the Spondyloarthritis Research Consortium of Canada (SPARCC) have collaborated to update the recommendations for the management of spondyloarthritis (SpA)...
Apr 01, 2014
Canadian Recommendations for Management of RA
The CRA has developed 2011/2012 recommendations for the pharmacological management of RA that take into consideration Canada’s current healthcare system. The recommendations address treatment questions identified from a national needs assessment survey of Canadian rheumatology professionals and are published in […]
Aug 01, 2012